MiR-193a-5p serves as an inhibitor in ovarian cancer cells through RAB11A

Yazhuo Wang1, Na Li2, Jing Zhao1

  • 1Department of Gynecology, Hebei General Hospital, China.

Insights

MicroRNA-193a-5p targets RAB11A, inhibiting ovarian cancer progression. This microRNA (miRNA) suppresses proliferation and invasion by repressing Wnt/β-catenin signaling, offering a potential therapeutic target for ovarian cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ovarian cancer diagnosis is often delayed, leading to low cure rates.
  • Understanding the pathogenesis of ovarian cancer is crucial for developing effective treatments.

Purpose of the Study:

  • To investigate the role of RAB11A messenger RNA (mRNA) and microRNA (miRNA) in ovarian cancer pathogenesis.
  • To elucidate the regulatory relationship between RAB11A and miR-193a-5p and their impact on ovarian cancer progression.

Main Methods:

  • Differential expression analysis of mRNA and miRNA data from public databases (GEPIA, GEO).
  • Quantitative polymerase chain reaction (qPCR) to measure RAB11A and miR-193a-5p levels.
  • Dual-luciferase assay to confirm targeting relationship.
  • Cellular assays (CCK-8, colony formation, Transwell) to assess cell behaviors.
  • Western blot to analyze protein expression (RAB11A, Wnt/β-catenin pathway proteins).

Main Results:

  • RAB11A mRNA was highly expressed, while miR-193a-5p was lowly expressed in ovarian cancer cells.
  • miR-193a-5p directly targets RAB11A.
  • RAB11A promotes ovarian cancer progression by activating Wnt/β-catenin signaling.
  • miR-193a-5p inhibits ovarian cancer cell proliferation, migration, and invasion.
  • Overexpression of RAB11A counteracted the suppressive effects of miR-193a-5p.

Conclusions:

  • miR-193a-5p acts as a tumor suppressor in ovarian cancer by targeting RAB11A.
  • The miR-193a-5p/RAB11A axis modulates Wnt/β-catenin signaling, impacting ovarian cancer progression.
  • Targeting the miR-193a-5p/RAB11A pathway may offer a novel therapeutic strategy for ovarian cancer.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.1K
Rab Proteins01:14

Rab Proteins

Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
4.1K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K